National Institute of Biological Sciences, Beijing
Patent Applications and Registrations
Patent applications and USPTO patent grants for National Institute of Biological Sciences, Beijing.The latest application filed is for "drug target of idiopathic pulmonary fibrosis".
- National Institute of Biological Sciences, Beijing - Beijing CN
| Patent | Date |
|---|---|
| Drug Target Of Idiopathic Pulmonary Fibrosis App 20220275055 - Tang; Nan ; et al. | 2022-09-01 |
| Prosthesis For The Lung And The Use Thereof App 20220273413 - Tang; Nan ; et al. | 2022-09-01 |
| Promoting immune responses Grant 11,229,707 - Shao , et al. January 25, 2 | 2022-01-25 |
| Adenosine Analog And Its Use In Regulating The Circadian Clock App 20210338706 - ZHANG; Erquan ; et al. | 2021-11-04 |
| Apoptosis Inhibitors App 20210309647 - Zhang; Zhiyuan ; et al. | 2021-10-07 |
| Treating male senescence Grant 11,090,307 - Wang , et al. August 17, 2 | 2021-08-17 |
| FTO Inhibitors App 20210238127 - Huang; Niu ; et al. | 2021-08-05 |
| Multiplexed Immunosignal Amplification Using Hybridization Chain Reaction-based Method App 20210198715 - LIN; Rui ; et al. | 2021-07-01 |
| Apoptosis inhibitors Grant 11,034,680 - Zhang , et al. June 15, 2 | 2021-06-15 |
| FTO inhibitors Grant 10,988,440 - Huang , et al. April 27, 2 | 2021-04-27 |
| Cathepsin C inhibitors App 20210114983 - Zhang; Zhiyuan ; et al. | 2021-04-22 |
| Entacapone-related compounds to treat macular degeneration Grant 10,980,766 - Huang , et al. April 20, 2 | 2021-04-20 |
| NTCP inhibitors Grant 10,961,231 - Zhang , et al. March 30, 2 | 2021-03-30 |
| NTCP Inhibitors App 20210040072 - Zhang; Zhiyuan ; et al. | 2021-02-11 |
| Promoting Immune Responses App 20200405869 - Shao; Feng ; et al. | 2020-12-31 |
| Hybridization Chain Reaction-based Method For Amplifying Immunosignals App 20200377926 - Lin; Rui ; et al. | 2020-12-03 |
| Necrosis inhibitors Grant 10,682,319 - Zhang , et al. | 2020-06-16 |
| Entacapone for treatment of obesity Grant 10,682,329 - Huang , et al. | 2020-06-16 |
| Necrosis Inhibitors App 20200182617 - Zhang; Zhiyuan ; et al. | 2020-06-11 |
| FTO Inhibitors App 20200148628 - Huang; Niu ; et al. | 2020-05-14 |
| Treating Male Senescence App 20200046714 - Wang; Xiaodong ; et al. | 2020-02-13 |
| Necrosis inhibitors Grant 10,555,920 - Zhang , et al. Feb | 2020-02-11 |
| FTO inhibitors Grant 10,532,976 - Huang , et al. Ja | 2020-01-14 |
| MLKL Inhibitors App 20190381052 - Zhang; Zhiyuan ; et al. | 2019-12-19 |
| Entacapone-related Compounds to Treat Macular Degeneration App 20190183842 - Huang; Niu ; et al. | 2019-06-20 |
| Apoptosis Inhibitors App 20190152960 - Zhang; Zhiyuan ; et al. | 2019-05-23 |
| Necrosis Inhibitors App 20190038578 - Zhang; Zhiyuan ; et al. | 2019-02-07 |
| Entacapone for treatment of obesity App 20180303788 - Huang; Niu ; et al. | 2018-10-25 |
| Necrosis inhibitors Grant 10,092,529 - Zhang , et al. October 9, 2 | 2018-10-09 |
| Necrosis Inhibitors App 20180263934 - Zhang; Zhiyuan ; et al. | 2018-09-20 |
| Entacapone for prevention and treatment of atherosclerosis Grant 10,004,715 - Huang , et al. June 26, 2 | 2018-06-26 |
| Necrosis inhibitors Grant 9,974,762 - Zhang , et al. May 22, 2 | 2018-05-22 |
| FTO Inhibitors App 20180118665 - Huang; Niu ; et al. | 2018-05-03 |
| 5-HT2B Antagonists App 20180111908 - Huang; Niu ; et al. | 2018-04-26 |
| 5-HT.sub.2B antagonists Grant 9,845,298 - Huang , et al. December 19, 2 | 2017-12-19 |
| 5-HT2B Antagonists App 20170349559 - Huang; Niu ; et al. | 2017-12-07 |
| Necrosis Inhibitors App 20170304237 - Zhang; Zhiyuan ; et al. | 2017-10-26 |
| Necrosis Inhibitors App 20170290790 - Zhang; Zhiyuan ; et al. | 2017-10-12 |
| 5-HT2B antagonists Grant 9,751,845 - Huang , et al. September 5, 2 | 2017-09-05 |
| Sesquiterpenoids Grant 9,670,226 - Lei , et al. June 6, 2 | 2017-06-06 |
| Sesquiterpenoids App 20170044180 - Lei; Xiaoguang ; et al. | 2017-02-16 |
| 5-HT2B Antagonists App 20170029385 - Huang; Niu ; et al. | 2017-02-02 |
| Entacapone for prevention and treatment of obesity and related metabolic diseases App 20140148383 - Huang; Niu ; et al. | 2014-05-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 